FindTrial
Sign In

A prospective clinical study for carvedilol in the treatment of portal hypertension in children

A prospective clinical study for carvedilol in the treatment of portal hypertension in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029153
Enrollment
Unknown
Registered
2020-01-16
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

portal hypertension

Interventions

Experimental group:carvedilol
control group:propranolol

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. confirmed portal hypertension; 2. under the age of 18 years; 3. Informed consent and cooperation in completing the study.

Exclusion criteria

Exclusion criteria: 1. Concomitant asthma; 2. Concomitant diabetes; 3. Concomitant with any heart disease; 4. Previous history of drug allergy; 5. previous gastroesophageal hemorrhage; 6. Merger with other serious diseases; 7. preparation for liver transplantation.

Design outcomes

Primary

MeasureTime frame
GI bleed;LSPS score;—

Secondary

MeasureTime frame
Esophageal and gastric varices;Routine blood;Splenomegaly situation;Ascites;—

Countries

China

Contacts

Public ContactChunbao Guo

Children's Hospital of Chongqing Medical University

guochunbao@foxmail.com+86 13032386618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026